Ron Finklestien
Kyverna Therapeutics Launches Upsized IPO to $297M
Kyverna Therapeutics Launches Upsized IPO to $297M
Chunumunu/iStock via Getty Images Kyverna Therapeutics, affectionately known as KYTX, has once again pushed the envelope by upsizing its proposed initial public offering – ...
An Uplifting Sojourn: NXP Semiconductors Shines in Q4 Earnings with Revenue Boost
NXP Semiconductors N.V. NXPI achieved a remarkable feat in the fourth quarter of 2023, as it reported non-GAAP earnings of $3.71 per share, surpassing ...
Former President Trump’s Legal Immunity Claim Rejected by Federal Appeals Court
Former President Trump’s Legal Immunity Claim Rejected by Federal Appeals Court
A Legal Setback for Donald Trump In a significant legal blow to former President Donald Trump, a federal appeals court delivered an unfavorable decision, ...
Insider Selling Activity for TD SYNNEX, Berkshire Hills Bancorp And Others
Insider Selling Activity for TD SYNNEX, Berkshire Hills Bancorp And Others
The Nasdaq Composite closed lower by around 0.2% on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could ...
Tanzania’s Support of SilverCorp’s Takeover of OreCorp
Tanzania’s Support of SilverCorp’s Takeover of OreCorp
Silvercorp pulled off a victory in January, outbidding Perseus Mining (TSX: PRU; ASX: PRU), the company behind 535,000 ounces of gold production last year ...
Annaly Capital Management Faces Quarterly Earnings Setback Amid High Interest Rates
Annaly Capital Management Faces Quarterly Earnings Setback Amid High Interest Rates
SOPA Images/LightRocket via Getty Images Annaly Capital Management (NYSE:NLY) is set to unveil its Q4 earnings performance after the markets close on Wednesday. Investors ...
FMC Corporation Shares Fall on Underwhelming Q4 Results, Other Stocks Experience Diverse Mid-Day Movement
King of Prussia-based FMC Corporation FMC experienced a dramatic descent in today’s trading session following the company’s disappointing fourth-quarter figures. The corporation recorded adjusted ...
Momentum Shifts: Gainers and Losers in the Market
Momentum Shifts: Gainers and Losers in the Market
Feb. 06, 2024 1:12 PM ET MSGS, WAVD, NVIV, KPTI, FCUV, WF, ZENV, DDC, FEBO By: Urvi Shah, SA News Editor Nikolay Pandev/E+ via ...
Unlocking Opportunities: Secondary Market Trends in Tech
This article is part of the LatAm Tech Weekly Series, written by Julia De Luca and powered by Nasdaq. Through Nasdaq’s global network, we ...
Bristol Myers Squibb Presents Abecma for FDA’s ODAC Review
Bristol Myers Squibb Presents Abecma for FDA’s ODAC Review
Bristol Myers Squibb BMY and its partner 2seventy bio, Inc. TSVT, will face a monumental moment as the FDA convenes a virtual meeting of ...
